CNAG-CRG, Centro Nacional de Análisis Genómico - Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Harry Perkins Institute of Medical Research, Nedlands, WA, Australia; Centre of Medical Research, University of Western Australia, Nedlands, WA, Australia.
Neuromuscul Disord. 2023 Feb;33(2):161-168. doi: 10.1016/j.nmd.2022.12.011. Epub 2022 Dec 22.
Primary acetylcholine receptor deficiency is the most common subtype of congenital myasthenic syndrome, resulting in reduced amount of acetylcholine receptors expressed at the muscle endplate and impaired neuromuscular transmission. AChR deficiency is caused mainly by pathogenic variants in the ε-subunit of the acetylcholine receptor encoded by CHRNE, although pathogenic variants in other subunits are also seen. We report the clinical and molecular features of 13 patients from nine unrelated kinships with acetylcholine receptor deficiency harbouring the CHRNA1 variant NM_001039523.3:c.257G>A (p.Arg86His) in homozygosity or compound heterozygosity. This variant results in the inclusion of an alternatively-spliced evolutionary exon (P3A) that causes expression of a non-functional acetylcholine receptor α-subunit. We compare the clinical findings of this group to the other cases of acetylcholine receptor deficiency within our cohort. We report differences in phenotype, highlighting a predominant pattern of facial and distal weakness in adulthood, predominantly in the upper limbs, which is unusual for acetylcholine receptor deficiency syndromes, and more in keeping with slow-channel syndrome or distal myopathy. Finally, we stress the importance of including alternative exons in variant analysis to increase the probability of achieving a molecular diagnosis.
原发性乙酰胆碱受体缺乏症是先天性肌无力综合征中最常见的亚型,导致肌肉终板上表达的乙酰胆碱受体数量减少,神经肌肉传递受损。AChR 缺乏症主要由 CHRNE 编码的乙酰胆碱受体 ε 亚单位的致病性变异引起,尽管也可见其他亚单位的致病性变异。我们报告了 9 个无亲缘关系的家族中 13 名患者的临床和分子特征,这些患者携带乙酰胆碱受体缺乏症,存在 CHRNA1 变异 NM_001039523.3:c.257G>A(p.Arg86His)纯合子或复合杂合子。该变异导致包含一个替代性剪接的进化外显子(P3A),从而导致无功能的乙酰胆碱受体 α 亚单位的表达。我们将该组的临床发现与我们队列中的其他乙酰胆碱受体缺乏症病例进行了比较。我们报告了表型的差异,强调了成年期面部和远端无力的主要模式,主要在上肢,这与乙酰胆碱受体缺乏症综合征不同,更符合慢通道综合征或远端肌病。最后,我们强调了在变异分析中包括替代外显子以增加获得分子诊断的可能性的重要性。